Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × titanium silicide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 26 Pancreatic Neoplasms 7 Colorectal Neoplasms 7 Biliary Tract Neoplasms 4 Recurrence 2 Neoplasm Metastasis 2 Gastrointestinal Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Advanced Gastric Cancer 2 Rectal Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Bile Duct Neoplasms 1 Advanced Solid Tumors 1

Interventions

Cisplatin 203 Radiotherapy 150 Cetuximab 115 pembrolizumab 96 Fluorouracil 78 Docetaxel 76 Paclitaxel 66 Carboplatin 66 Radiotherapy, Intensity-Modulated 59 Nivolumab 33 Radiation 28 Drug Therapy 26 Gemcitabine 22 Gefitinib 19 Erlotinib Hydrochloride 19 Standard of Care 17 Cyclophosphamide 17 durvalumab 16 Surgical Procedures, Operative 16 Magnetic Resonance Spectroscopy 16 Surveys and Questionnaires 15 Pemetrexed 15 atezolizumab 14 Bevacizumab 14 Low-Level Light Therapy 13 Filgrastim 13 Celecoxib 13 Capecitabine 13 Amifostine 13 Radiosurgery 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01645748 2012-07-20

TPSHNSCC

Chonnam National University Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡